

Enveda Biosciences

At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.
Founding Year
2019
Headquarters
Boulder
,
United States
Sector(s)
AI
Funding State
Pre-Seed
Seed
Series A
Series B+
Exited
Total Funding Amount
$187.90M
Funds that Investested
Dimension
A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth
They are currently investing through Dimension 1; a $350M fund investing at the earliest stages - incubation through growth - of drug discovery platforms, machine learning, tools, services, instruments & software companies digitizing the world of life sciences
They are currently investing through Dimension 1; a $350M fund investing at the earliest stages - incubation through growth - of drug discovery platforms, machine learning, tools, services, instruments & software companies digitizing the world of life sciences
Pre-Seed
Seed
Series A
Series B+
View Profile
FPV Ventures
$450M fund focused on investing in mission-driven founders. They invest across all stages with a preference for early-stage companies.
Pre-Seed
Seed
Series A
Series B+
View Profile
True Ventures
Invests in the brilliant people who bring ideas that matter to life. Founded in 2005, True Ventures has already invested $3.8B across 350+ teams.
True Ventures will only enter on the initial round of capital but will have reserves and continue to follow on in their existing portfolio. They target 20% + ownership on the initial investment.
True Ventures will only enter on the initial round of capital but will have reserves and continue to follow on in their existing portfolio. They target 20% + ownership on the initial investment.
Pre-Seed
Seed
Series A
Series B+
View Profile
Lifeforce Capital
Invests in digital health companies enabling new care delivery models or more efficient therapeutic development.
Pre-Seed
Seed
Series A
Series B+
View Profile
Silicon Valley Bank
Pre-Seed
Seed
Series A
Series B+
View Profile
Possible Ventures
Focused on frontier tech that can positively impact people and the planet.
Pre-Seed
Seed
Series A
Series B+
View Profile
Two Sigma Ventures
Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.
Pre-Seed
Seed
Series A
Series B+
View Profile
Village Global
Supercharges you to go from zero to one as quickly as possible by tapping Village's exceptional network.
Pre-Seed
Seed
Series A
Series B+
View Profile
Lux Capital
Partners with companies and founders trying to change the world, who want to upend paradigms, not just chase incremental progress. Over the past two decades, Lux has expanded from their New York City roots to Silicon Valley, and built a $4 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage.
Pre-Seed
Seed
Series A
Series B+
View Profile
Air Street Capital
Invests in AI-first technology and life science companies as early as possible and enjoy iterating through product, market, and technology strategy from day 1.
Pre-Seed
Seed
Series A
Series B+
View Profile
Wireframe Ventures
Specializes in helping extraordinary seed-stage founders on a mission to improve the health of people and planet.
Pre-Seed
Seed
Series A
Series B+
View Profile
Investors that Investested
Pegah Ebrahimi
Co-Founder and Managing Partner, FPV Ventures
Pegah Ebrahimi is an advisor to or investor in many category defining startups, including Snyk, Canva, Guild, Applyboard, PsiQuantum and DataRobot. Former COO of Morgan Stanley’s Technology Investment Banking, COO of Cisco’s multi-billion dollar Collaboration business, and the youngest global CIO of Morgan Stanley Bank.
Pre-Seed
Seed
Series A
Series B+
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets